TY - JOUR
T1 - 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
AU - the 2006 ASCCP-Sponsored Consensus Conference
AU - Wright, Thomas C.
AU - Massad, L. Stewart
AU - Dunton, Charles J.
AU - Spitzer, Mark
AU - Wilkinson, Edward J.
AU - Solomon, Diane
N1 - Funding Information:
We would like to thank all of the participants and formal observers to the 2006 Consensus Conference who worked so hard to develop the guidelines. Their names and organizations are available ( www.asccp.org ). We would like to thank Ms Kathy Poole for administrative support during the development of the guidelines and Dr Anna Barbara Moscicki, who chaired the adolescent working group. These guidelines were developed with funding from the American Society for Colposcopy and Cervical Pathology and the National Cancer Institute. Its contents are solely the responsibility of the authors and the American Society for Colposcopy and Cervical Pathology and do not necessarily represent the official views of the National Cancer Institute.
PY - 2007/10
Y1 - 2007/10
N2 - A group of 146 experts representing 29 organizations and professional societies met Sept. 18-19, 2006, in Bethesda, MD, to develop revised evidence-based, consensus guidelines for managing women with abnormal cervical cancer screening tests. The management of low-grade cervical intraepithelial neoplasia (CIN) grade 1 has been modified significantly. Previously, management depended on whether colposcopy was satisfactory and treatment using ablative or excisional was acceptable for all women with CIN 1. In the new guidelines, cytological follow-up is the only recommended management option for women with CIN 1 who have low-grade referral cervical cytology, regardless of whether the colposcopic examination is satisfactory. Treatment is particularly discouraged in adolescents. The basic management of women in the general population with CIN 2,3 underwent only minor modifications, but options for the conservative management of adolescents with CIN 2,3 have been expanded. Moreover, management recommendations for women with biopsy-confirmed adenocarcinoma in situ are now included.
AB - A group of 146 experts representing 29 organizations and professional societies met Sept. 18-19, 2006, in Bethesda, MD, to develop revised evidence-based, consensus guidelines for managing women with abnormal cervical cancer screening tests. The management of low-grade cervical intraepithelial neoplasia (CIN) grade 1 has been modified significantly. Previously, management depended on whether colposcopy was satisfactory and treatment using ablative or excisional was acceptable for all women with CIN 1. In the new guidelines, cytological follow-up is the only recommended management option for women with CIN 1 who have low-grade referral cervical cytology, regardless of whether the colposcopic examination is satisfactory. Treatment is particularly discouraged in adolescents. The basic management of women in the general population with CIN 2,3 underwent only minor modifications, but options for the conservative management of adolescents with CIN 2,3 have been expanded. Moreover, management recommendations for women with biopsy-confirmed adenocarcinoma in situ are now included.
KW - adenocarcinomas in situ of the cervix
KW - cervical intraepithelial neoplasia
KW - cryotherapy
KW - loop electrosurgical excision procedure
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=34648816774&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2007.07.050
DO - 10.1016/j.ajog.2007.07.050
M3 - Review article
C2 - 17904956
AN - SCOPUS:34648816774
SN - 0002-9378
VL - 197
SP - 340
EP - 345
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 4
ER -